CCX-354

CAS No. 1010073-75-2

CCX-354( GSK-2941266 | CCX354 | CCX354-C )

Catalog No. M10066 CAS No. 1010073-75-2

CCX-354 (GSK-2941266, CCX354-C, CCX354) is a potent, selective, orally-available CCR1 antagonist for the treatment of inflammatory diseases.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 626 Get Quote
10MG 888 Get Quote
25MG 1332 Get Quote
50MG 1782 Get Quote
100MG 2250 Get Quote
500MG 4410 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    CCX-354
  • Note
    Research use only, not for human use.
  • Brief Description
    CCX-354 (GSK-2941266, CCX354-C, CCX354) is a potent, selective, orally-available CCR1 antagonist for the treatment of inflammatory diseases.
  • Description
    CCX-354 (GSK-2941266, CCX354-C, CCX354) is a potent, selective, orally-available CCR1 antagonist for the treatment of inflammatory diseases such as rheumatoid arthritis (RA).Rheumatoid Arthritis Phase 2 Clinical.
  • In Vitro
    CCX354 shows potent activities in the chemotaxis assay, with IC50 < 100 nM.
  • In Vivo
    In vivo, CCX354 has in vivo anti-inflammatory activity and has superior pharmacokinetic properties.
  • Synonyms
    GSK-2941266 | CCX354 | CCX354-C
  • Pathway
    GPCR/G Protein
  • Target
    Chemokine Receptor
  • Recptor
    Chemokine Receptor
  • Research Area
    Inflammation/Immunology
  • Indication
    Rheumatoid Arthritis

Chemical Information

  • CAS Number
    1010073-75-2
  • Formula Weight
    451.915
  • Molecular Formula
    C22H22ClN7O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (221.28 mM)
  • SMILES
    COC1=C(C=CC(=C1)N2CCN(CC2)C(=O)CN3C4=C(C=CC=N4)C(=N3)C5=NC=CN5)Cl
  • Chemical Name
    2-(3-(1H-imidazol-2-yl)-1H-pyrazolo[3,4-b]pyridin-1-yl)-1-(4-(4-chloro-3-methoxyphenyl)piperazin-1-yl)ethan-1-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Tak PP, et al. Ann Rheum Dis. 2013 Mar;72(3):337-44. 2. Harcken C, et al. Bioorg Med Chem Lett. 2018 Nov 9. pii: S0960-894X(18)30880-1.
molnova catalog
related products
  • RS-102895 hydrochlor...

    A potent and specific CCR2 antagonist with binding IC50 of 360 nM; shows no significant affinity on CXCR1, CCR1, or CCR3.

  • E 6130

    A potent, selective, orally available CX3C chemokine receptor 1 (CX3CR1) modulator that inhibits the fractalkine-induced chemotaxis of human peripheral blood NK cells with IC50 of 4.9 nM.

  • Ladarixin sodium

    A novel allosteric, noncompetitive dual CXCR1/2 inhibitor that inhibits human polymorphonuclear leukocyte (PMN) migration to CXCL8 in vitro with IC50 of 0.7 nM.